Literature DB >> 9548617

IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease.

S Sulkanen1, P Collin, K Laurila, M Mäki.   

Abstract

BACKGROUND: An antiendomysium antibody test using human umbilical cord as antigen has recently been introduced.
METHODS: We determined IgA- and IgG-class antihuman umbilical cord (HUC-ab), antireticulin (ARA), and antigliadin antibodies (AGA) in 92 untreated adult coeliac patients, in 95 non-coeliac subjects, and in 4 coeliac patients with selective IgA deficiency. Tissue antibodies were measured with an indirect immunofluorescence method and AGA with an enzyme-linked immunosorbent assay.
RESULTS: Of adult coeliac patients 85% were positive for IgA-class HUC-ab, 78% were positive for ARA, and 80% for AGA; the specificity for HUC-ab and ARA was 100%, and for AGA 86%. Combination of HUC-ab, ARA, and high-titre AGA increased the sensitivity to 96% without loss of specificity. IgG-class HUC-ab was positive in 12% of coeliac patients, in all four coeliac patients with IgA deficiency, and in none of the controls.
CONCLUSIONS: The HUC-ab test is highly specific but not 100% sensitive for detecting adult coeliac disease. A combination of the IgA-class HUC-ab, ARA, and high-titre AGA tests is recommended. In selective IgA deficiency the IgG-class HUC-ab test seems to work well.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9548617     DOI: 10.1080/00365529850170810

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  10 in total

1.  Anti-endomysial antibody negative celiac disease: does additional serological testing help?

Authors:  A Dahele; K Kingstone; J Bode; D Anderson; S Ghosh
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

2.  Development of a novel rapid non-invasive screening test for coeliac disease.

Authors:  V Baldas; A Tommasini; C Trevisiol; I Berti; A Fasano; D Sblattero; A Bradbury; R Marzari; G Barillari; A Ventura; T Not
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

3.  Elevation of IgG antibodies against tissue transglutaminase as a diagnostic tool for coeliac disease in selective IgA deficiency.

Authors:  I R Korponay-Szabó; I Dahlbom; K Laurila; S Koskinen; N Woolley; J Partanen; J B Kovács; M Mäki; T Hansson
Journal:  Gut       Date:  2003-11       Impact factor: 23.059

4.  Development of an immunocapture method for measuring IgA antibodies to tissue transglutaminase in the sera of patients with coeliac disease.

Authors:  S El Alaoui; C Gresti
Journal:  Clin Exp Immunol       Date:  2006-04       Impact factor: 4.330

5.  Elevated serum anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease.

Authors:  Sara Ashorn; Hanna Raukola; Tuuli Välineva; Merja Ashorn; Bo Wei; Jonathan Braun; Immo Rantala; Katri Kaukinen; Tiina Luukkaala; Pekka Collin; Markku Mäki; Sari Iltanen
Journal:  J Clin Immunol       Date:  2008-05-22       Impact factor: 8.317

6.  Early microbial markers of celiac disease.

Authors:  Liisa Viitasalo; Laura Niemi; Merja Ashorn; Sara Ashorn; Jonathan Braun; Heini Huhtala; Pekka Collin; Markku Mäki; Katri Kaukinen; Kalle Kurppa; Sari Iltanen
Journal:  J Clin Gastroenterol       Date:  2014-08       Impact factor: 3.062

7.  Clinical benefit of gluten-free diet in screen-detected older celiac disease patients.

Authors:  Anitta Vilppula; Katri Kaukinen; Liisa Luostarinen; Ilkka Krekelä; Heikki Patrikainen; Raisa Valve; Markku Luostarinen; Kaija Laurila; Markku Mäki; Pekka Collin
Journal:  BMC Gastroenterol       Date:  2011-12-16       Impact factor: 3.067

8.  Small-intestinal TG2-specific plasma cells at different stages of coeliac disease.

Authors:  Minna Hietikko; Outi Koskinen; Kalle Kurppa; Kaija Laurila; Päivi Saavalainen; Teea Salmi; Tuire Ilus; Heini Huhtala; Katri Kaukinen; Katri Lindfors
Journal:  BMC Immunol       Date:  2018-12-06       Impact factor: 3.615

9.  Predictors of persistent symptoms and reduced quality of life in treated coeliac disease patients: a large cross-sectional study.

Authors:  Pilvi Paarlahti; Kalle Kurppa; Anniina Ukkola; Pekka Collin; Heini Huhtala; Markku Mäki; Katri Kaukinen
Journal:  BMC Gastroenterol       Date:  2013-04-30       Impact factor: 3.067

10.  Gastrointestinal Symptoms in Celiac Disease Patients on a Long-Term Gluten-Free Diet.

Authors:  Pilvi Laurikka; Teea Salmi; Pekka Collin; Heini Huhtala; Markku Mäki; Katri Kaukinen; Kalle Kurppa
Journal:  Nutrients       Date:  2016-07-14       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.